COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,441 Articles (22,835 medRxiv, 8,606 bioRxiv)

Most recent first Previous |  Page 566: Articles 5651-5660  | Next

The Use and Safety Risk of Repurposed Drugs for COVID-19 patients: Lessons Learned Utilizing the Food and Drug Administrations Adverse Event Reporting System
Alsuhaibani, D. S., Edrees, H. H., Alshammari, T. M.
10.1101/2022.12.10.22283298 — Posted: 2022-12-13
Reduced mortality among COVID-19 ICU patients after treatment with HemoClear convalescent plasma in Suriname
Bihariesingh-Sanchit, R., Bansie, R., Ramdhani, N., Mangroo, R., Bustamente, D., Diaz, E., Fung A Foek, C., Thakoer, I., Vreden, S. C., Choudry, Z., van 't Wout, A. B., Diavatopoulos, D. A., Nierich, A. P.
10.1101/2022.12.10.22283287 — Posted: 2022-12-13
Estimating the epidemic reproduction number from temporally aggregated incidence data: a statistical modelling approach and software tool
Nash, R. K., Cori, A., Nouvellet, P.
10.1101/2022.12.08.22283241 — Posted: 2022-12-13
The effect of vaccination on transmission of SARS-CoV-2 (COVID-19): a rapid review
Wiliams, J., Barrate, S., Winfield, T., Elston, L., McDermott, K., Jarrom, D., Hasler, E., Potter, C., Lewis, R., Cooper, A., Edwards, A. G.
10.1101/2022.12.09.22283255 — Posted: 2022-12-13
Tri-light Warning System for Hospitalized COVID-19 Patients]{A Tri-light Warning System for Hospitalized COVID-19 Patients: Credibility-based Risk Stratification under Data Shift
Xu, C., Xu, Q., Liu, L., Zhou, M., Xing, Z., Zhou, Z., Zhou, C., Li, X., Wang, R., Wu, Y., Wang, J., Zhang, L. J., Zhan, X., Gevaert, O., Lu, G.
10.1101/2022.12.11.22283309 — Posted: 2022-12-13
Emergence and Spread of SARS-CoV-2 Variants of Concern in Canada: a Retrospective Analysis from Clinical and Wastewater Data
CHAMPREDON, D., Becker, D., Peterson, S. W., Mejia, E., Hizon, N., Schertzer, A., Djebli, M., Xie, Y., Oloye, F. F., Asadi, M., Cantin, J., Brinkmann, M., McPhedran, K. N., Giesy, J. P., Mangat, C.
10.1101/2022.12.09.22283256 — Posted: 2022-12-13
Identifying and preventing fraudulent responses in online public health surveys: Lessons learned during the COVID-19 pandemic
Johnson, S. B., Wang, J., Calderon, G., Hager, E. R., Edwards, L. V., Berry, A. A., Liu, Y., Dinh, J., Summers, A. C., Connor, K. A., Collins, M. E., Pritchett, L., Marshall, B. R.
10.1101/2022.12.12.22283381 — Posted: 2022-12-13
Identification of a protein expression signature distinguishing early from organising diffuse alveolar damage in COVID-19 patients.
Ashwin, H., Milross, L., Wilson, J., Majo, J., Lee, J. T. H., Calder, G., Hunter, B., James, S., Lagos, D., Signoret, N., Filby, A., Bayraktar, O. A., Fisher, A. J., Kaye, P. M.
10.1101/2022.12.09.22283280 — Posted: 2022-12-13
Heat wave, COVID-19, and mortality excess in the 2022 summer: a cohort study on data from Italian surveillances.
Venturelli, F., Mancuso, P., Vicentini, M., Ottone, M., Storchi, C., Roncaglia, F., Bisaccia, E., Ferrarini, C., Pezzotti, P., Giorgi Rossi, P., The Reggio Emilia COVID19 Working group
10.1101/2022.12.12.22283336 — Posted: 2022-12-13
The Impact of COVID-19 Pandemic on Mental Health: A Scoping Review
Josiah, B. O., Ncube, F.
10.1101/2022.12.12.22283388 — Posted: 2022-12-13

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).